☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Exscientia
Exscientia Signs AI Drug Discovery Collaboration with Merck KGaA to Discover Novel Small Molecule Drug Candidates
September 20, 2023
Exscientia Entered into a Research Collaboration with Sanofi to Develop Cancer & Immunology Therapies
January 7, 2022
BMS Exercises its Option to Develop Exscientia's AI-Designed Drug Candidate
August 18, 2021
PharmaShots Weekly Snapshots (April 05 - 09, 2021)
April 9, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.